Corbus Pharmaceuticals
(NASDAQ:CRBP)
$42.73
0.01[0.02%]
Last update: 8:30AM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Corbus Pharmaceuticals Stock (NASDAQ:CRBP), Quotes and News Summary

Corbus Pharmaceuticals Stock (NASDAQ: CRBP) stock price, news, charts, stock research, profile.

Open$42.710
Close-
Volume / Avg.7.015K / 938.488K
Day Range42.460 - 44.170
52 Wk Range3.033 - 49.870
Market Cap$448.974M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
64
Short Interest
5.62%
Days to Cover1.96

Recent News

Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Avi Kapoor
American Eagle Reports Upbeat Earnings, Joins Kroger, Burlington Stores And Other Big Stocks Moving Higher On Thursday
U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Thursday.
Avi Kapoor
What's Going On With Cancer-Focused Corbus Pharmaceuticals Stock Today?
Corbus Pharmaceuticals announces a $82.2M public offering at $19.00 per share. Explore latest updates on CRB-701 clinical study.
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Corbus Pharmaceuticals Holdings Inc
Sector
Health Care
Industry
Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRBP
KALV

FAQ

Q

How do I buy Corbus Pharmaceuticals (CRBP) stock?

A

You can purchase shares of Corbus Pharmaceuticals (NASDAQ: CRBP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Corbus Pharmaceuticals's (CRBP) competitors?

A

Other companies in Corbus Pharmaceuticals’s space includes: KalVista Pharma (NASDAQ:KALV), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR), Replimune Group (NASDAQ:REPL) and PepGen (NASDAQ:PEPG).

Q

What is the target price for Corbus Pharmaceuticals (CRBP) stock?

A

The latest price target for Corbus Pharmaceuticals (NASDAQ: CRBP) was reported by Oppenheimer on Wednesday, March 13, 2024. The analyst firm set a price target for 58.00 expecting CRBP to rise to within 12 months (a possible 32.79% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Corbus Pharmaceuticals (CRBP)?

A

The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $43.679 last updated Today at April 16, 2024 at 9:40 AM EDT.

Q

Does Corbus Pharmaceuticals (CRBP) pay a dividend?

A

There are no upcoming dividends for Corbus Pharmaceuticals.

Q

When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?

A

Corbus Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Corbus Pharmaceuticals (CRBP) going to split?

A

There is no upcoming split for Corbus Pharmaceuticals.

Q

What sector and industry does Corbus Pharmaceuticals (CRBP) operate in?

A

Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch